4//SEC Filing
Asghar Najjam 4
Accession 0001209191-20-058333
CIK 0000850261other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:12 PM ET
Size
5.6 KB
Accession
0001209191-20-058333
Insider Transaction Report
Form 4
Asghar Najjam
Chief Financial Officer
Transactions
- Award
Stock Option
2020-11-12+120,000→ 120,000 totalExercise: $6.10Exp: 2030-11-12→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/4th of the original number of shares subject to the option shall vest on August 18, 2021, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001822126
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:12 PM ET
- Size
- 5.6 KB